INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
27/03/2026
Voltar para busca
Dado oficial do USPTO
EUROIMMUN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EUROIMMUN
ST13
US500000079226820Classe
1, 5, 9, 10
Pedido
79226820
Registro
5582980
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
28/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
06/09/2017
Data de registro
16/10/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/07/2025
Última transação
28/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Lübeck, DE
Examinador
FLETCHER, TRACY L
Localização atual
Historical data usage
Titulares e representantes
Titulares
EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Representantes
Kevan L. Morgan Seed IP Law Group LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparationsother than for medical or veterinary purposes; diagnostic preparations for scientific purposesimmobilized proteinsnucleic acid sequencesallergens and biological tissue cultures; unprocessed synthetic resin compounds in the form of microspheres used to incorporate various other substances; chemical test paper; chemically-treated nonmedical test strips for use in for use in analyzing nucleic acidsproteinscells and tissues; reagents for scientific and research use for labelingsequencing and fragment analysis of nucleic acids and proteins; polymeric membranes in chemical form for the separation of liquid gas and patient samples
Classe 5
Diagnostic preparations for medical and veterinary purposes in the fields of neurological diseasesinfectious diseasesautoimmune diseasesallergies and cancer; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposesnamely immobilized proteinsnucleic acid sequencesallergens and biological tissue cultures; reagent paper for medical or veterinary purposes; medical diagnostic test strips for testing bloodurine and saliva in the diagnosis of neurological diseasesinfectious diseasesautoimmune diseasesallergies and cancer; medical diagnostic reagents; biological and chemical preparations and reagents for medical or veterinary purposescells for medical or clinical usecultures of microorganisms for medical or veterinary useprotein arrays for medical diagnosis purposessynthetic peptides for the treatment of neurological diseasesinfectious diseasesautoimmune diseasesallergies and cancer and nucleic acid sequences for medical and veterinary purposes
Classe 9
Measuring devices for measuring pressuretemperaturechemical compound concentrations and optical signalssuch as fluorescence and chemiluminescence for diagnostic sample testingnot for medical use; sensors and detectors for testing UV fluorescence and chemiluminescence for diagnostic sample testingnot for medical use; laboratory apparatus for recordingtransmission or reproduction of diagnostic datasound or imagescamerasmicroscopesphotometersmicroplate photometersELISA (enzyme-linked immunosorbent assay) readersphotomultipliers and microplate readers; laboratory software for recordingtransmitting and reproducing diagnostic datasound and images; biochips for research or scientific purposes; plates having multi-well arrays that can be used in chemical analysisbiological analysis or patterning for scientificlaboratory or medical research use
Classe 10
Medical apparatus and instruments for medical examinations and medical diagnosisflatbed CT scannersdrum CT scanners and hand-held X-ray scanners; medical apparatus and instruments for apheresis
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
27/07/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
27/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14/07/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
14/04/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
16/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/04/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
29/01/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
29/01/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
16/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/07/2018
PUBO
PUBLISHED FOR OPPOSITION
31/07/2018
GPNX
NOTIFICATION PROCESSED BY IB
27/07/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/07/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/06/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/06/2018
CNFR
FINAL REFUSAL MAILED
15/06/2018
CNFR
FINAL REFUSAL WRITTEN
14/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2018
RFNT
REFUSAL PROCESSED BY IB
24/03/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/03/2018
RFRR
REFUSAL PROCESSED BY MPU
08/03/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/03/2018
MAFR
APPLICATION FILING RECEIPT MAILED
02/03/2018
CNRT
NON-FINAL ACTION WRITTEN
01/03/2018
DOCK
ASSIGNED TO EXAMINER
26/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/02/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/02/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EUROIMMUN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.